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Abstract
It is generally thought that during the contraction phase of an acute anti-viral T cell reponse, the effector T cells that escape
activation-induced cell death eventually differentiate into central memory T cells over the next several weeks. Here we
report that antigen-specific CD8T cells with the phenotype and function of central memory cells develop concomitantly
with effector T cells during vaccinia virus (vv) infection. As soon as 5 days after an intraperitoneal infection with vv, we could
identify a subset of CD44
hi and CD62L
+ vv-specific CD8 T cells in the peritoneal exudate lymphocytes. This population
constituted approximately 10% of all antigen-specific T cells and like central memory T cells, they also expressed high levels
of CCR7 and IL-7R but expressed little granzyme B. Importantly, upon adoptive transfer into naı ¨ve congenic hosts, CD62L
+,
but not CD62L
2 CD8 T cells were able to expand and mediate a rapid recall response to a new vv challenge initiated 6
weeks after transfer, confirming that the CD62L
+ vv-specific CD8 T cells are bonafide memory cells. Our results are thus
consistent with the branched differentiation model, where effector and memory cells develop simultaneously. These results
are likely to have implications in the context of vaccine design, particularly those based on vaccinia virus recombinants.
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Introduction
After a viral infection, naı ¨ve T cells expand enormously and
differentiate into effector cells that control the infection [1,2]. After
clearance of antigen, most of the effector T cells are eliminated by
activation-induced cell death (AICD). However during this
process, a few cells develop into memory T cells that survive for
extended periods of time and mediate a rapid and robust recall
response following a subsequent infection by the same pathogen
(reviewed in [3–5]. Based on the homing characteristics and
effector functions, considerable heterogeneity seems to exist within
the memory CD8 T cell population and at least two subsets have
been widely described [6–8]. One is designated as effector-
memory T cells (CD8
EM) that do not express the lymph node
homing molecules CD62L and CCR7. This cell subpopulation is
highly cytolytic, express high levels of molecules required for cell
killing such as granzymes, but express little IL-7R and persist after
antigen clearance predominately in nonlymphoid tissues [7]. The
other is called the central memory cells (CD8
CM), which are
CD62L
+, CCR7
+, IL-7R
+ and are found primarily in the
secondary lymphoid organs but can also reside in other tissues
[7,9,10]. CD8
CM also express high levels of CD44 and IL-7R.
They are also less cytolytic compared to CD8
EM, exhibit increased
survival with a capacity for antigen-independent self-renewal
[6,8,9]. CD8
CM are endowed with crucial immune functions and
can stimulate antigen-carrying DCs, thereby behaving as helpers
for TH1 and cytotoxic responses [6,8]. Furthermore, when
compared to CD8
EM cells, CD8
CM cells appear to have enhanced
sensitivity to antigen that leads to a rapid recall response [8]. Thus,
the CD8
CM subpopulation might represent the most desirable
memory CD8
+ T-cell subset.
The issue of how memory CD8 T cells are generated has
remained controversial [5,11–17], although broadly two models
are nowadays acknowledged. The linear differentiation model
predicts that memory CD8
+ T cells are direct descendants of
effector cells. According to this model, after Ag-activated naive
CD8
+ T cells differentiate into cytotoxic T lymphocytes (CTL),
some of these effector cells escape AICD and differentiate over
several weeks to fully express the properties of central memory
cells [9,11,15,18]. Conversely, the branched differentiation model
predicts that memory T cells are derived from a precursor that
precedes CTL and differentiate through a lineage parallel to
effectors [13,14,16,17]. Although the current thinking based on
extensive studies on LCMV infection favors a linear differentiation
model, a recent study by Reiner et al using a transgenic T cell
adoptive transfer model showed that memory and effector cells
can arise as a result of asymmetric division of CD8 T cells, with
one daughter cell becoming effector and the other daughter
becoming memory cell [17]. Notably, the differential commitment
of the two daughter cells is determined as early as the third division
upon encounter with an antigen. This model is also consistent with
our earlier study that had shown that effector and memory T cells
could be derived by differential cytokine treatment of activated T
cells in vitro, suggesting that effector differentiation is not a
prerequisite for memory cell generation [14]. However, whether
this is also true in the context of an infection in vivo is not clear. In
PLoS ONE | www.plosone.org 1 December 2008 | Volume 3 | Issue 12 | e4089this study, we address this issue in the context of vaccinia virus. We
were able to identify antigen-specific CD8 T cells with typical
features of memory T cells, concomitantly with effector T cells at
early time points after infection.
Results and Discussion
Identification of antigen-specific CD8
+ T cells with a
memory phenotype during an acute listeria
monocytogenes infection in cell transfer settings
We initially tested if memory-like cells can be identified at early
time points during Lm infection. We reasoned that if effector and
memory T cells are simultaneously generated from the asymmetric
division of a T cell after it responds to a microbial challenge, a
subpopulation with central memory phenotype should be
identified concurrently with the effector subset early after
infection. To test this, we used an adoptive transfer model using
CD8 T cells from P14 (specific for LCMV gp33–41) mice crossed
to T-GFP mice. The advantage of this system is that it allows the
detection of antigen specific cells by MHC-peptide tetramer
staining and simultaneously distinguishes the naı ¨ve from activated
T cells because, GFP expressed by naı ¨ve T cells is turned off once
the cells start dividing after activation [14]. C57 mice were
transferred with CD8 T cells isolated from naı ¨ve P14 xT-GFP
mice (Fig. 1a left panel) and 3 days later, infected ip with
recombinant Lm expressing gp33 epitope (rLmgp33, 10
4 CFU).
Eight days after infection, their peritoneal exudate lymphocytes
(PEL) were tested for the presence and phenotype of the
transferred donor cells. We chose to monitor the expression of
CD62L because it is a key marker that segregates the effector and
memory T cell subsets in combination with CD44, which is
expressed at high levels in all effector and memory but not in naı ¨ve
T cells [14,19]. This analysis revealed the presence of two major
subsets. A majority of gp33 tetramer
+ CD8 T cells (85.366.7%)
were CD44
+ CD62L
2, a profile that is reminiscent of the effector
phenotype. However a significant proportion of cells (14.765.9%)
was CD44
+ CD62L
+ a phenotype that generally typifies central
memory cells [6,14] (Fig. 1, a right panel and 1 b). Moreover they
also had lost GFP expression (Fig. 1c), indicating that they were
not input naı ¨ve cells, but were activated and had undergone cell
division. Thus, our data suggest that even at the acute phase of a
primary response, a population of post-mitotic CD44
hi CD62L
hi
CD8
+ T cells can be detected.
Antigen-specific CD8
+ T cells with a central memory
phenotype can also be detected at early time points after
a natural infection with vaccinia virus
One limitation of the above experiments is that the ‘unnatural’
numbers of antigen-specific T cell precursors present in the
adoptive transfer system may not accurately reflect the situation
that occurs during a natural infection. For instance, because of
excessive precursor numbers, the kinetics T cell differentiation
may be faster than that occurring in a natural infection. Thus, to
determine whether the observed CD8
+ T cell subset with a
memory phonotype (CD44
high CD62L
high) also occurs under
physiological conditions, we studied the antigen-specific CD8 T
cell differentiation during vaccinia virus infection. First, we
determined the kinetics of vaccinia-specific T cell response in
different organs following an ip infection with vv using the recently
described immunodominant B8R20–27 peptide (TSYFESV) [20] /
MHC pentamers. VV-specific CD8 T cell response peaked on day
8 and the maximal response was seen in the PEL, where the
B8R20–27 pentamer
+ cells constituted 10–20% of CD8 T cells,
followed by spleen, but few antigen-specific cells were detectable in
the other lymphoid organs (Fig. 2a, b). Because the maximal
response was seen in the PEL compartment, we used PEL CD8 T
cells for further studies. We examined the B8R20–27 pentamer
+
CD8 T cells for expression of CD62L and CD44 at different times
after infection. Strikingly, ,10–20% of B8R20–27 pentamer
+ cells
were CD44
hi and CD62L
+ and these cells could be detected as
soon as any pentamer positive cells could be detected, starting on
day 5 after infection (Fig. 2c). Moreover, they were continually
present throughout the 30-day observation period (Fig. 2c, d).
CD62L
+ cells peaked on day 8 (constituting ,20%) and remained
at approximately 10% of B8R20–27 pentamer
+ cells throughout the
study period (Fig. 2c, d). Thus, antigen-specific T cells with
CD62L
+ CD44
hi phenotype can also be detected at early periods
during a normal immune response to a viral challenge. To our
knowledge, this is the first report of detection of CD62L
+
pentamer
+ antigen specific CD8 T cells during an acute infection.
We further characterized this subset using markers that differen-
tiate naı ¨ve, effector and memory T cells in a four-color flow
cytometric analysis. On day 7 post-infection (at the peak of
response), the CD62L negative and CD62L positive B8R20–27
pentamer+ CD8 gated cells were examined for the expression of
CCR7, IL-7R, IL-15R, IL-18R (by external staining) and
granzyme B (by internal staining). As Fig. 3a shows, a majority
of CD62L
2 B8R20–27 pentamer
+ cells did not express CCR7 or
IL-7R, but expressed IL-15R, IL-18R and granzyme B, typical of
effector cells [8,21]. In contrast, a majority of CD62L
+ B8R20–27
pentamer
+ cells expressed CCR7 and IL-7R but little granzyme B.
However they also expressed IL-15R and IL-18R. We also tested
the phenotypic profile of CD62L
+ and CD62L
2 B8R20–27
Figure 1. Identification of CD44
hi CD62L
hi CD8 T cell popula-
tion during an acute infection with listeria monocytogenes. C57
mice were adoptively transferred with CD8 T cells isolated from
uninfected naı ¨ve P14XT-GFP mice (a, input, left panel) and infected with
rLmgp33. Eight days later, PELs from infected mice were examined for
the presence and phenotype of transferred cells. A representative dot
plot (a, right panel) and cumulative data from 6 mice (b) of CD44 and
CD62L expression by CD8 and gp33D
b tetramer-gated cells is shown.
The bar graph in (c) shows the mean fluorescence intensity (MFI) of GFP
expression by the transferred input donor cells and CD62L
+ and
CD62L
2 gp33D
b tetramer
+ cells in recipient mice after infection. Data
are presented as mean6s.d. from two independent experiments with 3
mice per experiment.
doi:10.1371/journal.pone.0004089.g001
Effector and Memory Cells
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at which any B8R20–27 pentamer
+ CD8 T cells could be discerned
(Fig.2c). Even here, the CD62L
+ antigen-specific cells expressed
CCR7 and IL-7R while the majority of CD62L
2 cells were
CCR7-, IL7R- (Fig. 3b). Thus, antigen-specific CD8 T cells
exhibiting a central memory phenotype can be detected as soon as
5 days after a vaccinia infection. Although naı ¨ve T cells also
express CCR7 and IL-7R and do not express granzyme B, the
CD62L
+ B8R20–27 pentamer
+ cells are unlikely to be naı ¨ve cells
because they expressed high levels of CD44, IL-15R and IL-18R
(Fig. 3a, b) and NKG2A (data not shown). Moreover, because
naı ¨ve T cells specific for a given TCR specificity are thought be
extremely few (estimated as 10–100 cells/animal in mice) [2,22],
no study has reported the presence of naı ¨ve antigen-specific T cells
during an infection. Further, naı ¨ve T cells circulate from blood to
lymphoid organs and are thought not to traffic to tissue sites of
infection such as PEL [23]. Additionally, it is highly unlikely that
naı ¨ve cells are being recruited into the peritoneal cavity even after
the clearance of the antigen (typically vaccinia infection is resolved
completely in 10–14 days) [24]. Taken together, our results
Figure 2. Kinetics and phenotype of antigen-specific CD8+ T response during an acute infection with vaccinia virus. C57BL/6 mice
were i.p. infected with vv and at different time points after infection, the presence of B8R20–27 pentamer
+ CD8
+ T cells in different tissues was assessed
by flow cytometry. Representative dot plot of results on day 8 (a) and cumulative data from 12 mice at different time points (b) on the presence of
B8R20–27 pentamer
+ CD8
+ T cells are shown (SPL, spleen; BM, bone marrow; PLN, peripheral (inguinal and axillaries) lymph nodes; MLN, mesenteric
lymph node; Para-A-LN, Para aortic lymph node). (c) Mice were infected with vv as in (a) and at indicated times post-infection, their PELs were tested
for the presence and phenotype of B8R20–27 CD8
+ T cells. Representative dot plots in the left panel show the percent of B8R20–27 pentamer
+ CD8
+ T
cells and the right panel shows CD62L and CD44 expression by the B8R20–27 pentamer
+ CD8
+ gated cells (n=4). (d) shows the cumulative data on
B8R20–27 pentamer
+ T cells as a percent of CD8 T cells in PEL (upper panel) and CD62L+ B8R20–27 pentamer
+ T-cells as a percent of total B8R
+
20–27 T-
cells (lower panel).
doi:10.1371/journal.pone.0004089.g002
Effector and Memory Cells
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+ B8R220–27 pentamer
+ cells are
not naı ¨ve, but have already been activated with antigen and
express the phenotypic features of central memory T cells and that
this cell population can be found concomitantly with effector T
cells during a primary immune response.
CD62L
+ B8R20–27 pentamer
+ cells mount long-term
memory response to rechallenge with vv
A hallmark of memory CD8 T cells is long-term survival and
ability to mediate a rapid recall response following rechallenge with
the pathogen. Because the CD62L
+ B8R20–27 pentamer
+ cells
exhibited the phenotypic characteristics of central memory cells, we
tested if they are also capable of memory functions. Since the
presence of neutralizing antibodies may complicate the analysis of
CD8 T cell memory function during a second infection in the same
mouse [24], we performed adoptive transfer experiments for these
studies using congeneic mice (Fig. 4a). We first tested the potential
for in vivo survival and function of CD62L
+ and CD62L
2 CD8 T
cell populations after transfer to naı ¨ve uninfected recipient mice.
C57 (Thy1.2) mice were infected with vv and 15 days later, their
PEL CD8 T cells were negatively selected using the R&D kit. The
CD62L
2 and CD62L
+ B8R20–27 pentamer positive cells constituted
,10 and ,0.9% respectively of PEL CD8 T cells. The CD8 T cells
were further immunomagnetically sorted and equivalent numbers
(10
6 donor cells/mouse) of CD62L
2 and CD62L
+ CD8 T cells
(C57, Thy1.2) were i.v. injected into naive congeneic mice (C57,
Thy1.1
+). Because TCR cross linking might restimulate the cells, we
did not use pentamer staining for sorting the cells. Since the
CD62L
+ B8R20–27 pentamer
+ cells constituted 10% of total B8R20–27
pentamer
+CD8 T cells in the PELand we transferred equal numbers
of CD62L
2 and CD62L
+ CD8 T cells, we actually transferred ,10
times more CD62L
2 than CD62L
+ B8R20–27 pentamer
+ cells/
Figure 3. Antigen-specific CD8+ T cells with both effector and central memory phenotype can be detected during an acute infection
with vaccinia virus. C57BL/6 mice were i.p. infected with vv and after 7 (a)o r5( b) days of infection, the phenotype of CD62L
+ and CD62L
2 B8R20–
27 CD8
+ T cells in the PELs examined by flow cytometry. The indicated marker expression by CD62L
+ and CD62L
2 B8R+20–27 CD8
+ gated T cells is
shown. Results are representative of three independent experiments.
doi:10.1371/journal.pone.0004089.g003
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5 CD62L
2 and 10
4 CD62L
+
pentamer
+ cells). To test the survival and proliferative capacity of
transferred donor cells, the recipient mice were challenged 8 days
a f t e rt r a n s f e rw i t hv vi . p .a n dt h e i rP E L sw e r ee x a m i n e df o rT h y 1 . 2
+
donor-derived pentamer+ cells 3 days after viral challenge. Despite
the fact that ,10 times more CD62L
2 than CD62L
+ cells had been
transferred, pentamer
+ CD8 T cells of donor origin (Thy1.2) could
only be detected in the CD62L
+ cell transferred mice (Fig. 4b, left
panel), suggesting that the CD62L
+, but not CD62L
2 transferred
cells could survive in a naı ¨ve host. The CD62L- cells isolated during
the acute phase of infection failed to survive in antigen-naı ¨ve hosts
after transfer probably because they represent fully differentiated
effector cells that are destined to die upon sudden withdrawal from
antigen and/or the cytokine milieu associated with infection (a
situation different from the endogenous CD62L- cells seen at late
periods after infection shown in Fig. 2c, which probably represent
‘‘effector memory’’ cells). In contrast, the CD62L+ cells were capable
of survival probably because they represent central memory type of
cells that are capable of survival in the absence of antigen. Moreover,
a substantial portion of CD62L
+ donor cells were also capable of
interferon-c production in response to ex-vivo stimulation with
B8R20–27 peptide (Fig. 3b, right panel). In addition, the viral burden
in the CD62L
+ CD8 T cell transferred mice was substantially lower
compared to CD62L
2 CD8 T cell transferred mice (Fig. 4c). The
Figure 4. CD62L
+ CD8 T cells isolated from vv-infected mice survive for long periods of time and mount a rapid recall response. (a)
Experimental approach for adoptive transfer experiments. PELs were harvested from day 7 or 15 vv-infected C57 (H-2D
b, Thy1.2
+) mice, CD8
+ T cells
were negatively selected and the presence of CD62L
+ and CD62L
2 B8R
+
20–27 CD8
+ cells confirmed. The CD62L
2 and CD62L
+ CD8
+ T-cell subsets were
further isolated (purity of isolated cells is shown in the bottom dot plots) and injected into naı ¨ve sex-matched congenic recipient C57 (H-2D
b,
Thy1.1
+) mice and the mice rested for different times before challenging with vv. (b) After 8 days of the transfer, the recipient mice were infected
with vv and 3 days later, their PELs were tested for the presence of donor-derived Thy1.2
+ B8R
+
20–27 CD8
+ T cells (left panel) or tested for intracellular
IFN-c production after ex vivo stimulation with B8R peptide-pulsed DC (right panel). One representative result from three mice each, transferred with
CD62L
2 or CD62L
+ CD8 T cells are shown. The numbers within the dot plots in the left panel represent percentage of total cells in the PEL and in the
right panel, they represent percentage of cytokine+ cells among all donor cells (c) Viral titer from the ovaries of the same recipient mice in (b) is
shown (n=3). (d) Six weeks after of the transfer of cells obtained from day 15 vv-infected mice, the recipient mice were challenged with vv and after
3 days, the presence of Thy1.2
+ donor-derived CD8 T cells tested in the CD62L
2 and CD62L
+ CD8 T cell transferred mice. Representative dot plot (left
panel) and cumulative data from four mice on the presence of donor derived Thy1.2
+ CD8 T cells are shown. The numbers within the dot plots in the
left panel represent percentage of total cells in the PEL. (e) Viral titers from the ovaries of the same recipient mice in (d) is shown (n=4). (f) After 6
weeks of the transfer of cells obtained from day 7 vv-infected mice, the recipient mice were challenged with vv and after 3 days, the presence of
Thy1.2
+ donor-derived CD8 T cells in the PELs were tested in the CD62L
2 and CD62L
+ CD8 T cell transferred mice. Representative dot plot (left panel)
and cumulative data from four mice on the presence of donor derived Thy1.2
+ CD8 T cells are shown. The numbers within the dot plots in the left
panel represent percentage of total cells in the PEL. (g) IFNc production by CD8 T cells in mice described in (f) is shown. (h) Viral titers from the
ovaries of the same recipient mice in (f) is shown (n=4).
doi:10.1371/journal.pone.0004089.g004
Effector and Memory Cells
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an endogenous host response elicited by coincidental transfer of vv at
thetime ofadoptivetransferbecause:(1)wewereunabletoisolatethe
virus from sorted cells used for transfer (data not shown) and (2) since
the CD62L+ or CD62L- cells isolated from the same infected mice
were used for transfer to separate recipient mice, if virus was
transferred along with donor cells, both groups of recipient mice
should have developed a protective immune response leading to the
presence of a substantial number of endogenous (Thy1.2-) pentamer+
CD8T cellsandlackofvirusuponrechallenge.However,whilethere
was no significant expansion of endogenous pentamer+ cells in both
groups of mice (Fig. 4b), there was high level virus replication in
CD62L- T cell transferred, but not in CD62L+ cell transferred
recipients. Taken together, these results show that while the antigen-
specific effector cells generated early after vv infection are destined to
die in an antigen free environment, the CD62L
+ memory-like cells
can survive and mediate effector function following a reinfection.
Although the above results suggest that the CD62L
+ cells
generated early after vaccinia virus infection survive in vivo for at
least 8 days and mount an effector response to rechallenge, true
memory cells should be capable of long-term survival.To test this, we
repeated the adoptive transfer experiments and this time rested the
recipient mice for 6 weeks before challenging with vv infection. Even
under these conditions, it is only the CD62L
+ transferred cells that
showed significant expansion (Fig. 4d). The donor derived CD62L
+
cells detected appear to be vaccinia-specific because when we
transferred similar numbers of CD62L+ CD8 T cells from naı ¨ve (vv
uninfected)mice, we could hardly detect any donor cellsin the PEL of
vv infected recipients (data not shown). Moreover, the recipient mice
that received the CD62L
+ cells (from vv-infected donors) showed
significantly reduced viral burden compared to CD62L
2 cell
transferred mice (Fig. 4e). Thus, the CD62L
+ CD8 T cells generated
after 15 days of infection appear to be memory T cells.
It has recently been suggested that memory precursors can be
identified within the effector cell population at early time points after
infection and that the conversion of effector to central memory CD8
T cells occurs gradually starting from the first week of stimulation in
vivo [9,25].Thus a possibility remained that by day 15 after vv
infection, memory cells could have arisen from differentiated effector
T cells. To test this possibility, we repeated the adoptive transfer
experiments using effector and memory phenotype cells isolated from
mice 7 days after infection (the limited number of antigen-specific T
cells produced precluded us from using the earliest time point of post-
infection day 5). CD62L
+ and CD62L
2 CD8 T cells from the PELs
of 7 day vv-infected Thy1.2 mice was isolated by FCAS-based cell
sorting and transferred to naı ¨ve Thy1.1 mice. The recipient mice
were rested for 6 weeks, infected with vv and 3 days later their PEL
examined for the presence of donor-derived Thy1.2
+ CD8 T cells.
Even here, a significant number of donor-derived CD8 T cells and
interferon c production could be detected in the CD62L
+ cell
transferred mice but not in the CD62L
2 celltransferred mice (Fig. 4f,
g). Moreover, viral titers were also lower in the CD62L
+ cell
transfe rr edmiceco mp aredtoCD 62L
2celltransferredmice(Fig. 4h).
Thus, as early as 7 days after an acute vaccinia infection, central
memory-like CD8 T cells, with capacity to survive in the absence of
antigen for long periods of time and to expand and protect against a
reinfection can be detected.
Taken together our results suggest that central memory CD8 T
cells are generated simultaneously with effector T cells during
vaccinia infection. These results are in agreement with the studies
from the Reiner’s group which found that memory CD8 T cells
arise by asymmetric division of antigen-stimulated cells, implying
that both cell types can arise from a common progenitor very early
in the response to infection [17]. However it should be cautioned
that from our studies, we can not definitively conclude that the
same antigen-specific CD8 T cell precursor is giving rise to both
effector and memory cells.
Unlike our results with vaccinia infection, cells with the phenotypic
and functional characteristic of central memory cells are not seen in
the acute phase of LCMV infection and based on those results, it has
been concluded that memory cells are descendants of effector cells
and develop gradually after the clearance of antigen [25]. Why is the
situation is different in vaccina infection is not clear. However,
numerous variables including antigen density and persistence,
costimulation, cytokines and CD4 help are known to determine the
quantity, quality and location of memory cells [26]. Although both vv
and LCMV are acute infections, the antigen load and persistence is
more in LCMV than vv. Moreover, the induction of costimulatory
molecules as well as the response to blockade of costimulatory
interaction also differs between LCMVand vv[27].Furthermore, we
have previously shown that cytokines IL-2 and IL-15 can
differentially regulate the fate of antigen activated CD8 T cells into
becomingeithereffectorormemorycells[14].Thus,itispossiblethat
differences in the antigen density/costiumlatory signals or cytokine
response between LCMV and vaccinia infection could account for
the differences between our results and those reported with LCMV in
the literature. A study by Bachman et al also reported that the
balance between effector and memory T cells is governed by the
degree of antigen load and time [28]. However, using gp33-specifc
TCR Tg CD8 T cells as surrogate antigen-specific cells, they found
that although CD62L+ memory cells proliferate in vivo upon
infection with both LCMV and vaccinia, they clear LCMV but not
vaccinia efficiently. This is not consistent with our results because we
found both proliferation and protection to be mediated by central
memory rather than effector cells following vaccinia rechallenge.
Differences in the experimental systems might account for these
differences. For e.g. Bachman et al used LCMV gp33-specifc TCR
Tg memory CD8 T cells generated during an LCMV infection as
surrogate vaccinia-specific cells to detect responses against a
recombinant vaccinia expressing gp33 (and thus are looking at one
surrogate epitope-responding T cells), we used memory CD8T cells
during a native vaccinia infection (containing all native vaccinia-
responding cells) to measure protection following rechallenge.
Similarly, Richards et al also used a influenza NP68 epitope-specific
T cells as surrogate vaccinia specific T cells to measure responses to a
recombinant vv expressing NP68 epitope and found that proteolytic
cleavage of CD62L is required for efficient clearance of vaccinia
infection [29]. This is however, not inconsistent with our results since
the wild type vaccinia-specific T cells (in this study) are not defective
for CD62L cleavage.
Finally, it is also noteworthy that most studies on LCMV have
focused on events in the spleen after an iv infection, while we
characterized the cell populations after vaccinia infection in the
peritoneal cavity after an ip infection. Thus, another possibility is
that the activated CD8 T cell fate may also vary with different
routes of infection and/or at different tissue sites of immune
response. Further studies are needed to test these hypotheses,
which may have implications particularly in improving the design
of vaccinia-based vaccines.
Materials and Methods
Mice
C57BL/6 (C57; H-2D
b, Thy1.2
+), C57BL/6 (C57; H-2D
b,
Thy1.1
+) were purchased from Jackson Laboratory. P14 X T-GFP
mice have been described [14]. All mice were maintained in
specific pathogen free conditions and used when they were 6–10
weeks of age. All animal experiments had been approved by the
Effector and Memory Cells
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(Formerly CBR Institute for Biomedical Research).
MHC-peptide tetramers, Pentamers and antibodies
MHC H-2D
b gp33 tetramers were obtained from Biosource
International and MHC H-2D
b Pro5
Tm Pentamer (B8R peptide:
TSYFESV) was custom synthesized at ProImmune. Antibodies to
mouse CD8, Thy1.1, Thy1.2, CD44, CD62L, and INF-c were
purchased from BD PharMingen. Antibodies to CCR7 and IL7R
were from eBioscience. Antibodies to IL-15R and IL-18R were
from R&D Systems. Immunostaining and flow cytometric analysis
of cell-surface phenotypes and intracellular cytokines were done as
described earlier [30].
Adoptive transfer and listeria infection
These were done as described earlier [30]. Breifly, naive CD8
+
T cells were purified from the splenocytes of P14xT-GFP mice
[14] by negative selection using the murine CD8 subset isolation
kit (R&D Systems) and wild type C57 mice were injected i.v. with
8610
6 purified CD8 T cells. On day 3 post-transfer, recipient
mice were injected i.p. with 10
4 CFU of a recombinant strain of
Listeria monocytogenes that expresses the LCMV gp33–41 epitope
(rLmgp33) and, at day 8 postinfection, their peritoneal exudates
lymphocytes (PELs) were harvested.
Viral infection. Mice were infected ip with 10
6 PFU/mouse
in 200 ml PBS of vv (WR strain, ATCC) and at different times
after infection their PELs, spleens, and other lymphoid organs
were harvested for experiments.
Cell sorting and adoptive transfer studies
Cells harvested from the PELs of infected C57 mice (H-2D
b,
Thy1.2
+), were first enriched for CD8+ T cells using the murine
CD8 subset isolation kit (R&D Systems). Negatively selected CD8
T cells were then stained with CD62L-PE, followed by incubation
with PE-coated Miltenyi beads. Positively and negatively selected
cells were subsequently isolated using a Miltenyi miniMACS
system. In some experiments (to test memory function after 7 days
of infection), the CD62L
+ and CD62L
2 CD8 T cells were FACS
sorted using FACSAria cell sorter (Becton Dickinson, San Jose,
CA). Age and sex-matched recipient C57 (H-2Db, Thy1.1+) mice
were i.v. injected with (1610
6 cells/mouse) purified CD62L
+ or
CD62L
2 cells. At day 8 or 6 weeks post-transfer, recipient mice
were i.p. challenged with vaccinia virus (10
6 PFU/mouse in 200 ml
PBS) and 3 days later, their peritoneal exudates lymphocytes
(PELs) and ovaries were harvested. When examining the recipient
mice PELs for the presence of donor derived T cells, the cells were
also stained with Thy1.2 Abs to distinguish them from the Thy1.1
host CD8 T cells. For testing IFN-c response, syngeneic bone
marrow-derived DC were pulsed with B8R20-27 peptide (TSY-
FESV; 5 mg/ml; synthesized at ProImmune), washed and used to
stimulate PELs of secondary recipient mice. Non peptide-pulsed
BMDC served as controls. After 18 hours of the co-cultures, the
intracellular IFN-c production was measured as described
previously [30].
Virus titration
Serial dilutions of homogenates of ovaries harvested from
recipient mice were inoculated on CV-1 cells and after 2 days,
stained with neutral red/formalin and the plaques were counted
manually.
Statistical analysis
Differences in values between experimental groups were
examined for significance with Graph Pad Prism software using
Student t test. We considered probability (P) values ,0.05 as
significant. Values are presented as means6SEMs.
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